INMB compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

INMBInmune Bio, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

INMBInmune Bio, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only INMB 0

None

Shared 0

No disclosed counterparties: INMB.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Role chip = supplier or customerSource: SEC EDGAR

INMBInmune Bio, Inc.

1.19▼−10.77%· post 1.19· delayed

Mkt cap$35.5MRevenue$50,000Q1 FY25Revenue—

AMGNAmgen Inc

461.49▼−3.55%· post 461.14· delayed

After hoursNov 5 '26delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

After hoursNov 5 '26delayed

INMBInmune Bio, Inc.

AMGNAmgen Inc

1.19▼−10.77%post 1.19delayed

Price

461.49▼−3.55%post 461.14delayed

$35.5M

Mkt cap

$258.8B

Q1 FY25$50,000

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

INMB1.19▼−10.77%vsAMGN461.49▼−3.55%After hoursNov 5 '26delayed